
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 269
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 269
Showing 1-25 of 269 citing articles:
Biomineralized MnO2 Nanoplatforms Mediated Delivery of Immune Checkpoint Inhibitors with STING Pathway Activation to Potentiate Cancer Radio-Immunotherapy
Zheng Deng, Min Xi, Cai Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4495-4506
Closed Access | Times Cited: 87
Zheng Deng, Min Xi, Cai Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4495-4506
Closed Access | Times Cited: 87
Copper in cancer: from limiting nutrient to therapeutic target
Xiaolong Tang, Zaihua Yan, Yandong Miao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 54
Xiaolong Tang, Zaihua Yan, Yandong Miao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 54
The role of tumor-associated macrophages in tumor immune evasion
Ruizhe Huang, Ting Kang, Siyu Chen
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 44
Ruizhe Huang, Ting Kang, Siyu Chen
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 44
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 42
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 42
Oncogenes and tumor suppressor genes: functions and roles in cancers
Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 20
Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 20
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
AMPK–a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Na Wang, Bofang Wang, Ewetse Paul Maswikiti, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Na Wang, Bofang Wang, Ewetse Paul Maswikiti, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 17
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 17
Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access | Times Cited: 2
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access | Times Cited: 2
Tailoring traditional Chinese medicine in cancer therapy
Shuiquan Li, Xi Chen, Hui Shi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Shuiquan Li, Xi Chen, Hui Shi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
Shenglong Li, Yue Kang, Yu Zeng
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189033-189033
Closed Access | Times Cited: 41
Shenglong Li, Yue Kang, Yu Zeng
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189033-189033
Closed Access | Times Cited: 41
Optimized strategies of ROS-based nanodynamic therapies for tumor theranostics
Yifan Di, Ruizhu Deng, Zhu Liu, et al.
Biomaterials (2023) Vol. 303, pp. 122391-122391
Closed Access | Times Cited: 37
Yifan Di, Ruizhu Deng, Zhu Liu, et al.
Biomaterials (2023) Vol. 303, pp. 122391-122391
Closed Access | Times Cited: 37
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers
Manli Zhou, Xiaoyun He, Cheng Mei, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Manli Zhou, Xiaoyun He, Cheng Mei, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Therapeutic application of manganese-based nanosystems in cancer radiotherapy
Shuya Pan, Zhengwei Sun, Bo Zhao, et al.
Biomaterials (2023) Vol. 302, pp. 122321-122321
Closed Access | Times Cited: 26
Shuya Pan, Zhengwei Sun, Bo Zhao, et al.
Biomaterials (2023) Vol. 302, pp. 122321-122321
Closed Access | Times Cited: 26
PD-1/PD-L1 and DNA Damage Response in Cancer
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 530-530
Open Access | Times Cited: 23
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 530-530
Open Access | Times Cited: 23
Targeting tumor-infiltrating tregs for improved antitumor responses
Diyuan Qin, Yugu Zhang, Pei Shu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Diyuan Qin, Yugu Zhang, Pei Shu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 13
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 13
Antitumor immunostimulatory activity of the traditional Chinese medicine polysaccharide on hepatocellular carcinoma
Yang Liu, Jiawen Wu, Huiqin Hao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Yang Liu, Jiawen Wu, Huiqin Hao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
Shufa Tan, Qin Zheng, Wei Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Shufa Tan, Qin Zheng, Wei Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression
Yu Wang, Jiazhou Li, Shingo Nakahata, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7346-7346
Open Access | Times Cited: 9
Yu Wang, Jiazhou Li, Shingo Nakahata, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7346-7346
Open Access | Times Cited: 9
A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses
Weizhou Wang, Junying Fan, Chi Zhang, et al.
Microbiological Research (2024) Vol. 282, pp. 127668-127668
Closed Access | Times Cited: 8
Weizhou Wang, Junying Fan, Chi Zhang, et al.
Microbiological Research (2024) Vol. 282, pp. 127668-127668
Closed Access | Times Cited: 8
Quercetin exerts anti-tumor immune mechanism by regulating IL-6/JAK2/STAT3 signaling pathway to deplete Treg cells
Yu‐Pei Liao, Xiaoqing Xie, Chu Zhang, et al.
Toxicon (2024) Vol. 243, pp. 107747-107747
Closed Access | Times Cited: 8
Yu‐Pei Liao, Xiaoqing Xie, Chu Zhang, et al.
Toxicon (2024) Vol. 243, pp. 107747-107747
Closed Access | Times Cited: 8
Targeting LSD1 in cancer: Molecular elucidation and recent advances
Wenpeng Cai, Chu Xiao, Tao Fan, et al.
Cancer Letters (2024) Vol. 598, pp. 217093-217093
Closed Access | Times Cited: 8
Wenpeng Cai, Chu Xiao, Tao Fan, et al.
Cancer Letters (2024) Vol. 598, pp. 217093-217093
Closed Access | Times Cited: 8
Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma
Siyu Jing, Dan Liu, Na Feng, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Siyu Jing, Dan Liu, Na Feng, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8